Pharmafile Logo

Point of Difference

Point of Difference was formed in 2004 with a clear focus on the selection, assessment and development of leaders and managers. Our belief is that at key points in both life and business, the right decision can have long-reaching implications for success and fulfilment. Our aim is to be there at those points of difference to help challenge and shape thinking.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Company Details

43 The Croft, Haddenham, Aylesbury, Bucks, HP17 8AS, United Kingdom
+44 (0)7851 744 508

 Latest Content from PMHub 

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

The new pharma marketing playbook

Do you know about the 5 key areas that must be in your pharma marketing playbook?

Pharma needs to evolve from customer-centricity to stakeholder-centricity

Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders.

How to plan, execute and refine an excellent congress experience

Medical congresses are one of the most important and intensive marketing activities a company can undertake. Here, Account Director Dolan Desai and Senior Creative Copywriter Dale Choate give you the...

How can pharma help the NHS capitalise on its data?

Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services

21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare

The 21st Century Cures Act has transformed the US drug development landscape. David Cooney explores the implications of the Act for pharmaceutical companies and reveals how it can be leveraged.

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

Spotlight on Events

Porterhouse has delivered many successful global programmes in 2017 so far. Read about our dedicated events team ...